COQ2 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with COQ2 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with COQ2 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with COQ2 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with COQ2 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000173702 - mucin 13, cell surface associated

Gene

ENSG00000103249 - Cl-/H+ antiporter 7

Gene

ENSG00000127831 - villin 1

Gene

ENSG00000112818 - meprin A subunit alpha

Gene

ENSG00000042832 - thyroglobulin

Gene

ENSG00000130313 - 6-phosphogluconolactonase

Gene

ENSG00000112303 - vanin 2

Gene

ENSG00000119844 - aftiphilin

Gene

ENSG00000129055 - anaphase promoting complex subunit 13

Gene

ENSG00000151846 - poly(A) binding protein cytoplasmic 3

  • Gene

    ENSG00000173702 - mucin 13, cell surface associated


  • Gene

    ENSG00000103249 - Cl-/H+ antiporter 7


  • Gene

    ENSG00000127831 - villin 1


  • Gene

    ENSG00000112818 - meprin A subunit alpha


  • Gene

    ENSG00000042832 - thyroglobulin


  • Gene

    ENSG00000130313 - 6-phosphogluconolactonase


  • Gene

    ENSG00000112303 - vanin 2


  • Gene

    ENSG00000119844 - aftiphilin


  • Gene

    ENSG00000129055 - anaphase promoting complex subunit 13


  • Gene

    ENSG00000151846 - poly(A) binding protein cytoplasmic 3

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.